AstraZeneca's IMFINZI and IMJUDO combination shows progression benefit in liver cancer

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/9/2026

1. AAPL
2. SPY
3. RBRK
4. NUVL
5. GOOGL
6. APLD
7. CPB
8. SPCX
9. MTN
10. USO

Go back to AstraZeneca's IMFINZI and IMJUDO combination shows progression benefit in liver cancer
ASTRAZENECA PLC (NASDAQ: AZN) Delayed: 92.77 --0 (-0%)
Previous Close $92.77    52 Week High $35.04 
Open $92.77    52 Week Low $26.97 
Day High $92.77    P/E N/A 
Day Low $92.77    EPS $0.00 
Volume 914,111